tirzepatide 12.5mg/ml Mounjaro 12.5 Mg at ₹ 25781/vial | Tirzepatide Injection in Nagpur Mounjaro (Tirzepatide) 12.5mg/0.5mL Pre-Filled Pen

Phase 4: Therapeutic dose (Weeks 13-16) Dose: 8 mg or 9 mg once weekly What to expect: Strong appetite suppression Significant ongoing weight loss Possible temporary GI flare during escalation Many reach 10-15% weight loss by this phase Tips: This is where most people stabilize 8 mg may be sufficient for manyhigher isn't always better Continue lifestyle optimization Regular check-ins with healthcare provider Phase 5: Maximum dose (Week 17+) Dose: 12 mg once weekly (if tolerated and needed) What to expect: Maximum therapeutic effect Continued weight loss (averaging 20%+ by 48 weeks in trials) GI side effects may be manageable or may persist Some achieve 25-30%+ weight loss Tips: Not everyone needs to reach 12 mg Lower doses may provide sufficient results Balance efficacy with tolerability Maintenance may involve dose reduction For general peptide dosing principles, see our peptide dosage calculator guide

Mounjaro (tirzepatide) is a newer medication that mimics both GLP-1 and GIP, another hormone involved in metabolism

Gloria H.

Diabetes status: Type 2 diabetes, prediabetes, or none